Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02885311 · ClinicalTrials.gov registry record · Phase 1
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
A Phase 1 study of Alcohol Drinking and Alcoholism, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT02885311 is a Phase 1 study of Alcohol Drinking and Alcoholism that has completed, run by Northwell Health. The registered enrollment target is 27 participants, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02885311, a Phase 1 study of Alcohol Drinking and Alcoholism, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to develop and test a care model to treat excessive drinking and alcohol use disorders in the primary care setting. The goal of this research study is to increase the identification and treatment of problem drinking in the primary care setting. Individuals will be asked to participate in this study because routine screening and assessment conducted at your primary care clinic indicates that you have recently exceeded healthy drinking limits as outlined by the National Institutes of Alcohol and Alcoholism.
Conditions Studied
Interventions
- DRUG Naltrexone
- BEHAVIORAL Brief Advice
- BEHAVIORAL Motivation Enhancement Therapy
- BEHAVIORAL Modified Behavioral Self-Control Therapy
- OTHER Referral to specialty substance use disorder treatment
Study Locations (1)
New York
- Northwell Health - Great Neck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-01 |
| Est. Completion | 2018-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02885311
The ClinicalTrials.gov registry entry for NCT02885311 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (96% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 5 interventions - of which Naltrexone is the first listed.
NCT02885311 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02885311 about?
NCT02885311 is a clinical study titled "Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home". The purpose of this research study is to develop and test a care model to treat excessive drinking and alcohol use disorders in the primary care setting. The goal of this research study is to increase the identification and treatment of problem drinking in the primary care setting. Individuals will ...
What is the current status of trial NCT02885311?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2017-01. Estimated completion is 2018-10.
What conditions does trial NCT02885311 study?
This clinical trial studies the following conditions: Alcohol Drinking, Alcoholism, Alcohol Abuse, Alcohol-Related Disorders, Alcohol Use Disorders.
What interventions are being tested in trial NCT02885311?
The interventions under investigation include: Naltrexone (DRUG), Brief Advice (BEHAVIORAL), Motivation Enhancement Therapy (BEHAVIORAL), Modified Behavioral Self-Control Therapy (BEHAVIORAL), Referral to specialty substance use disorder treatment (OTHER).
Who is sponsoring clinical trial NCT02885311?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02885311 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotinic Receptor Genetic Variation and Alcohol Reward
RECRUITING · Phase 1
-
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RECRUITING · Phase 1
-
Opioid Modulation and Neural Reward Activation in Healthy Adults
COMPLETED · Phase 1
-
A Novel Compound for Alcoholism Treatment
COMPLETED · Phase 1
-
The Behavioral Effects of Opioids and Alcohol
COMPLETED · Phase 1
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.